LAUSR

We had the great pleasure of reading the article titled "Intrathecal dexmedetomidine and postoperative pain: A systematic review and meta-analysis of randomized controlled trials" written by Paramasivan et al. The authors concluded that "the analgesic role of intrathecal dexmedetomidine is promising due to its ability to significantly increase postoperative analgesic duration when compared with placebo" (Paramasivan et al., 2020). At the outset, the authors should be congratulated for conducting a well-designed study and examining a very important topic in perioperative medicine. Nevertheless, we have several suggestions and queries that we would like to communicate with the authors.